<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01331811</url>
  </required_header>
  <id_info>
    <org_study_id>ANRS12229 PAANTHER 01</org_study_id>
    <nct_id>NCT01331811</nct_id>
  </id_info>
  <brief_title>Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon)</brief_title>
  <official_title>Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam) and Africa (Burkina Faso, Cameroon) ANRS 12229 PAANTHER 01 (Pediatric Asian African Network for Tuberculosis and HIV Research)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut Pasteur, Cambodia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Pediatric Hospital, Cambodia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Angkor Hospital for Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pediatric Hospital Nhi Dong 1, Ho Chi Minh City, Vietnam</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Number 2, Ho Chi Minh City, Vietnam</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpital Necker-Enfants Malades, Paris, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Groupe Hospitalier Pitie-Salpetriere</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CHRU Arnaud de Villeveuve, Montpellier, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRD, Yaounde, Cameroon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fondation Chantal Biya,Yaounde, Cameroon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CHU Sourô Sanou, Bobo Dioulasso, Burkina Faso</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Muraz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Pasteur du Cameroun</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier D'essos</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Childhood tuberculosis (TB) accounts for 11% of the total 9 million annual TB cases and the
      difficulty of its diagnosis is increased in case of HIV infection in children.

      The aim of this study is to improve TB diagnosis in HIV-infected children by developing a new
      diagnostic algorithm incorporating new tools available such as:

        -  interferon gamma release assays (IGRAs), as alternative to the tuberculin skin test

        -  alternative specimen collection methods such as string test (or Enterotest (R)),
           nasopharyngeal aspirates and stools samples, as alternatives to gastric aspirate

        -  the Xpert MTB/RIF assay
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tuberculosis diagnostic algorithm</measure>
    <time_frame>3 years</time_frame>
    <description>Development of an effective diagnostic algorithm for pediatric tuberculosis after evaluating the following diagnostic tests and sampling methods:
Clinical examination
Chest X-rays
Abdominal ultrasound
IGRAs
Xpert MTB/RIF
Gastric aspirate
String test
Nasopharyngeal aspirate
Stools sample
Sputum samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the QuantiFERON(R)-TB Gold In-Tube</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluation of the sensitivity, specificity, positive and negative predictive values of an in-vitro Interferon Gamma Release (IGRAs) : the QuantiFERON(R)-TB Gold iIn-Tube, for the diagnosis of TB in HIV infected children</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of two in-vitro IGRAs</measure>
    <time_frame>6 months</time_frame>
    <description>Comparison of the performances of two in-vitro IGRAs: the QauntiFERON(R)-TB Gold In-Tube and the T.SPOT-TB(R), for the diagnosis of tuberculosis in a sub-group of HIV infected children.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of TB diagnosis sampling procedures actually performed</measure>
    <time_frame>6 months</time_frame>
    <description>To assess the feasibility of the following TB sampling procedures:
the string test
the nasopharyngeal aspirate
stool sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the morbidity (IRIS, drug toxicity and other opportunistic infections) and mortality in TB-HIV co-infected children</measure>
    <time_frame>at 6 month of TB treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity and sensibility of TB diagnosis sampling procedures compared to TB diagnosis gold standard (sputum or gastric aspirate culture)</measure>
    <time_frame>6 months</time_frame>
    <description>To assess the performance of the following TB sampling procedures:
the string test
the nasopharyngeal aspirate
stools sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the Xpert MTB/RIF assay</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluate the sensitivity, specificity, positive and negative predictive values of the Xpert MTB/RIF assay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of the Xpert MTB/RIF test to the gold standard (culture of gastric aspirates or sputum)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of the performance Xpert MTB/RIF assay on sampling methods other than the reference method (gastric aspirate and sputum)</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluation of the Xpert MTB/RIF assay on the following sampling methods:
String test
Nasopharyngeal aspirates
Stool samples</description>
  </secondary_outcome>
  <enrollment type="Actual">441</enrollment>
  <condition>HIV</condition>
  <condition>Tuberculosis</condition>
  <condition>Pediatrics</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Development of a diagnosis algorithm</intervention_name>
    <description>At entry in the study, HIV infected children with suspected tuberculosis will undergo a complete evaluation including:
interview on anamnesis
clinical examination
evaluation of HIV infection stage
hematology and biochemistry tests
CD4 count
HIV viral load
IGRA
chest radiograph
Abdominal ultrasonograph to detect abdominal lymphadenopathy
Tuberculin skin test
gastric aspirates, sputum and string tests according to the age of children
nasopharyngeal aspirate
stool sample
lymph node fine needle aspirate or other specimen collection if applicable
Diagnosis and treatment of all participating children will be done according to national guidelines. The children will be followed-up for 6 months until the end of their anti-TB treatment. For the analysis of data and the validation of the algorithm, children will be randomized into 2 groups. Data from Group I will be used to develop the algorithm; data from Group II will be used to validate it.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children aged from 0 to 13 years

          -  confirmed HIV infection

          -  suspicion of tuberculosis

          -  informed consent signed by at least one parent or guardian

          -  on ARVs or not

        Exclusion Criteria:

          -  history of anti TB treatment started in the past 2 years

          -  on going tuberculosis treatment

          -  Suspicion of exclusive extra-thoracic tuberculosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier Marcy, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Institut Pasteur in Cambodia, Phnom Penh, Cambodia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vibol Ung, MD</last_name>
    <role>Study Chair</role>
    <affiliation>National Pediatric Hospital, Phnom Penh, Cambodia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Sourô Sanou</name>
      <address>
        <city>Bobo Dioulasso</city>
        <country>Burkina Faso</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Pediatric Hospital</name>
      <address>
        <city>Phnom Penh</city>
        <country>Cambodia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Angkor Hospital for Children</name>
      <address>
        <city>Siem Reap</city>
        <country>Cambodia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier d'Essos</name>
      <address>
        <city>Yaounde</city>
        <country>Cameroon</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Mère Enfant Chantal Biya</name>
      <address>
        <city>Yaounde</city>
        <country>Cameroon</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pediatric Hospital Nhi Dong 1</name>
      <address>
        <city>Ho Chi Minh City</city>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pediatric Hospital Nhi Dong 2</name>
      <address>
        <city>Ho Chi Minh City</city>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pham Ngoc Thach Hospital</name>
      <address>
        <city>Ho chi Minh ville</city>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Burkina Faso</country>
    <country>Cambodia</country>
    <country>Cameroon</country>
    <country>Vietnam</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2011</study_first_submitted>
  <study_first_submitted_qc>April 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2011</study_first_posted>
  <last_update_submitted>August 4, 2015</last_update_submitted>
  <last_update_submitted_qc>August 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>Tuberculosis</keyword>
  <keyword>Diagnosis</keyword>
  <keyword>Pediatrics</keyword>
  <keyword>Asia</keyword>
  <keyword>Africa</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

